Purchase Order 75N91024P00239
- Not listed
- Beckman Coulter, Inc. received a $20,554 firm fixed price purchase order from the National Cancer Institute (NCI), a component of the National Institutes of Health, awarded on March 12, 2026, with an ultimate completion date of March 11, 2027. The contract, which carries no small business set-aside designation, will be performed in Bethesda, Maryland. As a subsidiary of Danaher Corporation and a leading provider of biomedical testing equipment and laboratory instrumentation, Beckman Coulter...
- This is a federal service contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Beckman Coulter, Inc., a global manufacturer of biomedical testing equipment and laboratory instruments. The $20,909 firm fixed-price delivery order contract has an ultimate completion date of April 30, 2026. The contract is not set aside for small businesses. Beckman Coulter, a subsidiary of Danaher Corporation, has significant experience...
- This contract is for the maintenance and preventive maintenance of a Labcyte ECHO525 acoustic liquid handler for the National Cancer Institute (NCI) at the National Institutes of Health (NIH). It was awarded to Beckman Coulter Inc. as a firm-fixed price purchase order for one year, with four one-year option periods. The contract has a total potential value of $130,179.94. The original solicitation was a small business set-aside, seeking a contractor to provide software service, technical...
- The National Cancer Institute (NCI) awarded a delivery order valued at $23,464.93 to Beckman Coulter, Inc. for preventive maintenance services on a Cytoflex instrument. This firm fixed-price delivery order, issued on April 1, 2026, with an ultimate completion date of February 28, 2027, is being performed at Beckman Coulter's facility in Brea, California. The contract carries no set-aside designation, consistent with Beckman Coulter's status as a large, for-profit organization and preferred...
- The National Cancer Institute (NCI) awarded a $20,763 firm fixed-price delivery order to Beckman Coulter, Inc. on December 1, 2024, under the FY26 Unlimited Delivery Order (UDO) Initiative Service Agreement. The work is scheduled for completion by November 30, 2025, and will be performed at Beckman Coulter's location in North Bethesda, Maryland. This contract was not issued under a small business set-aside designation. Beckman Coulter, a subsidiary of Danaher Corporation and a major supplier...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health (NIH), to Beckman Coulter, Inc., a global manufacturer of biomedical testing equipment, laboratory instruments, and related services. The $10,861.50 contract is for the provision of Beckman scientific equipment and instruments, with a performance period ending on September 29, 2025. Beckman Coulter, a subsidiary of Danaher Corporation,...
- This federal contract award, valued at $5,717.00, was issued by the National Cancer Institute (NCI) to Beckman Coulter, Inc. The contract is for medical laboratory testing services, specifically the provision of full service maintenance, repair, and relocation for Beckman Coulter instruments. Beckman Coulter, a subsidiary of Danaher Corporation, is a provider of clinical laboratory equipment, reagents, and related services. This award is not associated with a set-aside program. Based on...
- This is a federal contract award to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, to provide full service agreement and repair of Beckman Coulter laboratory equipment systems for the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health (NIH). The contract has a ceiling value of $16,787.00 and is a firm fixed price delivery order contract with a period of performance through November 29, 2024. The contract does not have a set-aside designation....
- This federal contract award is for a Delivery Order between the National Cancer Institute (NCI) and Beckman Coulter, Inc. to provide full-service maintenance, repair, and relocation support for Beckman Coulter instruments. The contract is for a firm fixed price of $9,249.31 and has an ultimate completion date of March 31, 2014. Beckman Coulter, a subsidiary of Danaher Corporation, is a manufacturer of clinical laboratory equipment, reagents, and services. The company has held numerous federal...
- This federal contract award was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to Beckman Coulter, Inc., a subsidiary of Danaher Corporation. The $4,204 firm-fixed-price delivery order is for full service maintenance, repair, and relocation of Beckman Coulter clinical laboratory instruments. The contract has a period of performance through March 30, 2014 and does not have a set-aside designation. Beckman Coulter has a history...
The National Cancer Institute (NCI) has awarded a firm fixed-price purchase order to Beckman Coulter, Inc. for service maintenance of a Beckman Coulter ECHO 525 High Volume, Rapid Acoustic Liquid Handler at its Bethesda, Maryland facility. The contract, valued at $139,010.67, was awarded on April 1, 2024, and carries an ultimate completion date of March 31, 2029. No small business set-aside designation applies to this award. As a subsidiary of Danaher Corporation, Beckman Coulter is a global manufacturer of biomedical testing equipment and laboratory instruments that serves as a critical vendor to the federal government, providing specialized scientific instrumentation and comprehensive maintenance and technical support services essential to the biomedical research missions of multiple federal agencies. This maintenance contract supports NCI's laboratory operations by ensuring continued functionality of the acoustic liquid handling system, which is a specialized instrument used in high-throughput sample processing and biomedical research applications. Beckman Coulter has extensive experience fulfilling federal requirements across the National Institutes of Health and its constituent institutes, including the NCI, through multiple service agreements, preventative maintenance contracts, and repair services. The company maintains several principal Indefinite Delivery Contracts with federal agencies valued up to $10 million, positioning it as a strategic long-term provider of specialized biomedical laboratory equipment and consumables across the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $24.0k | 3/4/26 | |
| P00001 | Exercise an Option | $27.5k | 3/5/25 | |
| Not listed | Not listed | $26.1k | 3/15/24 |